Black Titan to Investigate Cryptocurrency Investment Approaches
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Oct 06 2025
0mins
Black Titan's Strategic Plans: Black Titan is exploring strategic initiatives in the cryptocurrency space, including potential investments in digital currencies and a digital currency holding strategy.
CEO's Insights on Market Opportunities: CEO Chay W. J. emphasized the benefits of leveraging debt, equity, and cash flow for building crypto holdings, highlighting the current favorable conditions for investing in emerging coins due to optimism from the new Trump administration and interest from major financial institutions.
Analyst Views on BTTC
About BTTC
Black Titan Corporation is a holding company that operates through its subsidiaries, Titan Pharmaceuticals Inc. (TTNP), and TalenTec Sdn Bhd (TalenTec). TTNP is a pharmaceutical company that was previously developing therapeutics utilizing the proprietary long-term drug delivery platform, ProNeura, for the treatment of select chronic diseases. ProNeura consists of a small, solid implant made from a mixture of ethylene-vinyl acetate (EVA) and a drug substance. The resulting product is a solid matrix that is designed to be administered sub-dermally in a brief, outpatient procedure and is removed in a similar manner at the end of the treatment period. TalenTec is a provider of HCM software in Malaysia. It has introduced numerous human capital management (HCM) solutions to that market, such as Oracle PeopleSoft HCM, Oracle PeopleSoft Financials, Sunfish Workplaze HR, DayForce HCM, and MiHCM Cloud, through its holistic, integrated and reliable services.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
